TriangleHEALTH PROFESSIONAL · SOURCE READING
Neoadjuvant chemotherapy for unresectable liver metastases
Source: Colon Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: February 12, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.
Context: Treatment of Stage IV and Recurrent Colon Cancer / Treatment Options for Liver Metastasis
Patients with hepatic metastases that are deemed unresectable will occasionally become candidates for resection if they have a good response to chemotherapy. These patients have 5-year survival rates similar to patients who initially had resectable disease.[17] There is no consensus on the best regimen to use to convert unresectable isolated liver metastases to resectable liver metastases.
Source links and citations
Publication references
Read the original reference and check its publication notices.
Preserved source evidence · Not medical advice